Poland · Delayed Price · Currency is PLN Pure Biologics Company Description
Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases.
It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules.
The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use.
It also engages in the development of non-systemic therapies for use in treating patients suffering from neurological autoimmune disorders, including neuromyelitis optica and myasthenia gravis; and provides contract research for pharmaceutical and biotechnology companies.
Pure Biologics S.A. was incorporated in 2010 and is headquartered in Wroclaw, Poland.
| Country | Poland |
| Founded | 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7 |
Contact Details
Address: ul. Dunska 11 Wroclaw, 54-427 Poland | |
| Phone | 48 795 61 18 11 |
| Website | purebiologics.com |
Stock Details
| Ticker Symbol | PUR |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLPRBLG00010 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Filip Jelen M.B.A., Ph.D. | Co-founder and President of the Management Board |
| Dr. Pieter Spee | Chief Scientific Officer and Member of the Management Board |
| Przemyslaw Dudek | Head of Information Technology |
| Dr. Ewelina Swiderek Ph.D. | Head of Project Management |